This $2 Billion Cancer Discovery Makes Radiation Look Outdated

#outsmartcancer #precisiononcology #immunotherapy #drdinoprato #targetedcancercare

Something most cancer patients are never told:
the radiation plan you receive is often influenced by the machine a hospital owns, not by what’s best for your cancer biology.

In this episode of Outsmart Cancer, Dr. Dino Prato breaks down the radiation wars — and introduces a disruptive technology that may change oncology entirely: ultrasound-based tumor destruction. Data shows that 40–50% of radiation therapy is palliative, meaning it’s designed to slow disease or reduce symptoms rather than eliminate cancer. The real question becomes: what are we doing during that time?

Dr. Prato explains why radiation has long been an adjuvant tool, how hospital economics and reimbursement drive its overuse, and why newer technologies often struggle to gain adoption. He then introduces histotripsy and sonodynamic therapy, which use focused sound waves to “melt” tumors without radiation. This process creates a tumor lysate rich in antigens, neoantigens, and DAMPS — powerful immune signals that can be repurposed into systemic immunotherapy.

Using precision oncology principles — DNA sequencing, RNA transcriptomics, immune profiling, spatial biology, and AI-guided analysis — this lysate can be combined with immunotherapy, phytotherapeutic adjuvants, and nanoparticle delivery to stimulate whole-body immune response, not just local tumor control.

This episode explores why ultrasound-based approaches may replace large portions of radiation oncology in the future, why adoption is slow, and how immune-centric precision care shifts cancer treatment from palliative delay to strategic immune activation.

🎯 What You’ll Learn in This Episode:
• Why 40–50% of radiation therapy is palliative
• How hospital ownership influences radiation decisions
• The difference between radiation destruction and immune training
• What histotripsy and sonodynamic therapy are
• How tumor lysate becomes immunotherapy
• Why ultrasound avoids many radiation side effects
• How precision oncology integrates sound, data, and immunity
• Why disruptive cancer technology takes years to reach patients

📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more: https://www.envita.com/?utm_source=Dr...

📞 Speak with a care coordinator: 866-830-4576

“Cancer care isn’t just about killing tumors — it’s about teaching the immune system what to do next.”

🧬 About Dr. Dino Prato and Envita Medical Centers
My life's work at Envita Medical Centers has been a mission to help patients find hope when they've run out of options. As a pioneer in precision personalized medicine, I founded Envita Medical Centers to offer next-level care. We use state-of-the-art testing and treatments that are not only data-driven but also precisely targeted to each individual.

By the grace of God, we've been able to help many families. Our approach isn't about treating a disease; it's about treating a unique person and providing a custom blueprint for healing. We believe every life is precious and unrepeatable, and we approach each patient with the love and dignity they deserve. The message we give them is one of life and hope.

📍 Envita Medical Centers – At Envita Medical Centers in Scottsdale, AZ, we believe in a radical, loving approach to patient care. Our unique campus is home to a dedicated team of over 400 professionals, including doctors (MD, DO, NMD), pharmacists, nurses, and researchers, all working together in a seamless ecosystem.

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.
You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperin...